These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 34300274)

  • 1. Chemotherapy for Biliary Tract Cancer in 2021.
    Sasaki T; Takeda T; Okamoto T; Ozaka M; Sasahira N
    J Clin Med; 2021 Jul; 10(14):. PubMed ID: 34300274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
    Abdel-Rahman O; Elsayed Z; Elhalawani H
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011746. PubMed ID: 29624208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Practical Guide for the Systemic Treatment of Biliary Tract Cancer in Canada.
    Ramjeesingh R; Chaudhury P; Tam VC; Roberge D; Lim HJ; Knox JJ; Asselah J; Doucette S; Chhiber N; Goodwin R
    Curr Oncol; 2023 Jul; 30(8):7132-7150. PubMed ID: 37622998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapeutic options for biliary tract cancer: current standard of care and new perspectives.
    Filippi R; Lombardi P; Quarà V; Fenocchio E; Aimar G; Milanesio M; Leone F; Aglietta M
    Expert Opin Pharmacother; 2019 Dec; 20(17):2121-2137. PubMed ID: 31550186
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biliary tract cancer: on the way to a personalized therapy].
    Sinn M; Wege H; Stein A
    Dtsch Med Wochenschr; 2020 Apr; 145(7):442-446. PubMed ID: 32236923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current progress in perioperative chemotherapy for biliary tract cancer.
    Ioka T; Shindo Y; Ueno M; Nagano H
    Ann Gastroenterol Surg; 2023 Jul; 7(4):565-571. PubMed ID: 37416744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The path to personalized treatment in advanced and metastatic biliary tract cancers: a review of new targeted therapies and immunotherapy.
    Demols A; Bucalau AM; Mans L
    Curr Opin Oncol; 2022 Jul; 34(4):403-411. PubMed ID: 35837710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative adjuvant chemotherapy for resectable cholangiocarcinoma.
    Luvira V; Satitkarnmanee E; Pugkhem A; Kietpeerakool C; Lumbiganon P; Pattanittum P
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD012814. PubMed ID: 34515993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational development of combination therapies for biliary tract cancers.
    Harding JJ; Khalil DN; Fabris L; Abou-Alfa GK
    J Hepatol; 2023 Jan; 78(1):217-228. PubMed ID: 36150578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic treatment of advanced or recurrent biliary tract cancer.
    Zhang W; Zhou H; Wang Y; Zhang Z; Cao G; Song T; Zhang T; Li Q
    Biosci Trends; 2020 Nov; 14(5):328-341. PubMed ID: 32830166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy for cholangiocarcinoma: An update.
    Ramírez-Merino N; Aix SP; Cortés-Funes H
    World J Gastrointest Oncol; 2013 Jul; 5(7):171-6. PubMed ID: 23919111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of chemotherapy in treatments for biliary tract cancer.
    Furuse J; Kasuga A; Takasu A; Kitamura H; Nagashima F
    J Hepatobiliary Pancreat Sci; 2012 Jul; 19(4):337-41. PubMed ID: 22456744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical treatment for cholangiocarcinoma.
    Adeva J; Sangro B; Salati M; Edeline J; La Casta A; Bittoni A; Berardi R; Bruix J; Valle JW
    Liver Int; 2019 May; 39 Suppl 1():123-142. PubMed ID: 30892822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted therapy for biliary tract cancer.
    Furuse J; Okusaka T
    Cancers (Basel); 2011 May; 3(2):2243-54. PubMed ID: 24212807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant and neoadjuvant therapy for biliary tract cancer: a review of clinical trials.
    Nara S; Esaki M; Ban D; Takamoto T; Shimada K; Ioka T; Okusaka T; Ishii H; Furuse J
    Jpn J Clin Oncol; 2020 Dec; 50(12):1353-1363. PubMed ID: 33037430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the treatment of biliary tract cancers.
    Uson Junior PLS; Bogenberger J; Borad MJ
    Curr Opin Gastroenterol; 2020 Mar; 36(2):85-89. PubMed ID: 31972599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of prognosis for unresectable biliary tract cancer.
    Sasaki T; Isayama H; Nakai Y; Takahara N; Sasahira N; Kogure H; Mizuno S; Yagioka H; Ito Y; Yamamoto N; Hirano K; Toda N; Tada M; Omata M; Koike K
    World J Gastroenterol; 2013 Jan; 19(1):72-7. PubMed ID: 23326165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholangiocellular Carcinoma.
    Vogel A; Saborowski A
    Digestion; 2017; 95(3):181-185. PubMed ID: 28288474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemotherapy for Biliary Tract Cancer].
    Woo SM
    Korean J Gastroenterol; 2017 Mar; 69(3):172-176. PubMed ID: 28329919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase 2 study of copanlisib in combination with gemcitabine and cisplatin in advanced biliary tract cancers.
    Tan ES; Cao B; Kim J; Al-Toubah TE; Mehta R; Centeno BA; Kim RD
    Cancer; 2021 Apr; 127(8):1293-1300. PubMed ID: 33289918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.